Company profile
Vicapsys Life Sciences, Inc. CIK 1468639
Industry
Pharmaceutical Preparations
Headquarters
Cumming, GA 30041
Fiscal year end
2023 (FY)
Key Financials
Revenue
—
Net income
-$1.18M
Total assets
$39.7K
Total liabilities
—
Stockholders' equity
-$1.93M
Cash & equivalents
$9.4K
Operating income
-$1.05M
Operating cash flow
-$417.5K
Capital expenditures
—
Fiscal year 2023, via 10-K filed 2024-10-21. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
—
Equity / assets
-4,863.5%
CapEx / revenue
—
Operating cash flow / net income
0.35×
Derived from the fiscal year 2023 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2023
—
-$1.18M
$39.7K
—
-$1.93M
2022
—
-$984.8K
$72.0K
—
-$950.8K
2021
—
-$236.9K
$594.3K
—
-$121.7K
2020
—
-$765.8K
$404.1K
—
-$449.1K
2019
—
-$1.41M
$698.4K
—
$302.0K
Company Details
SIC code
2834
State of incorporation
FL
Active filer
Yes
Most recent SEC filing
Form 15-12G
2025-03-27
Financials filed via
Form 10-K
filed 2024-10-21
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Cumming, GA 30041
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:28 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.